| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 08/17/2005 | EP0832189B1 Process for controlling sialylation of proteins produced by mammalian cell culture |
| 08/17/2005 | EP0742826B1 Multivariant il-3 hematopoiesis fusion protein |
| 08/17/2005 | CN1656122A Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 08/17/2005 | CN1656114A Novel pancortin-pablo protein interactions and methods of use thereof |
| 08/17/2005 | CN1654663A Recombinant human VEGF and bFGF eukaryon expression vector, fused protein and applications thereof |
| 08/17/2005 | CN1654657A Novel streptococcus antigens |
| 08/17/2005 | CN1215083C Monoclonal antibody for resisting human liver cancer and its application |
| 08/16/2005 | US6929932 An isolated polynucleotide molecule encoding an IL-21 antagonist polypeptide of specefic amino acid sequence; culturing |
| 08/16/2005 | CA2098533C Carrier system against gnrh |
| 08/16/2005 | CA2086936C Method for producing members of specific binding pairs |
| 08/11/2005 | WO2005072045A2 The combined use of glp-1 agonists and gastrin for regulating blood glucose levels |
| 08/11/2005 | US20050176930 Nucleotide sequences coding tumor associated antigen for use in diagnosis, prevention and treatment of cell proliferative disorders; mimetics; antitumor agents |
| 08/11/2005 | US20050176108 Physiologically active polypeptide conjugate having prolonged in vivo half-life |
| 08/11/2005 | US20050176070 Immunoglobulin array for use in monitoring polypeptide binding |
| 08/11/2005 | US20050175606 Cyclic single-chain trispecific antibody |
| 08/11/2005 | US20050175582 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 08/11/2005 | CA2595619A1 Enhanced secretion/retention of growth hormone releasing hormone (ghrh) from muscle cells by species-specific signal peptide |
| 08/11/2005 | CA2554599A1 Novel brain natriuretic peptide variants and methods of use thereof |
| 08/11/2005 | CA2554458A1 The combined use of glp-1 agonists and gastrin for regulating blood glucose levels |
| 08/11/2005 | CA2554440A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer |
| 08/10/2005 | EP1561757A1 Modified factor VIII |
| 08/10/2005 | EP1560917A1 Method of immobilising a protein to a zeolite |
| 08/10/2005 | EP1151117A4 Intein-mediated protein ligation of expressed proteins |
| 08/10/2005 | EP1123398B1 Molecular pathogenicide mediated plant disease resistance |
| 08/10/2005 | CN1653084A Mutants of the P4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 08/10/2005 | CN1653080A Lymphatic and blood endothelial cell genes |
| 08/10/2005 | CN1651576A Production method and process of recombination chicken beta-alexin |
| 08/10/2005 | CN1651464A Chain antibiotics / granul cell-macrophage colong stimulating factor fusion protein |
| 08/10/2005 | CN1214244C Immuno assay solid-phase supporter, reagent kit, preparation and use thereof |
| 08/10/2005 | CN1214115C Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug |
| 08/10/2005 | CN1214114C Activatable recombinant neurotoxins |
| 08/09/2005 | US6926898 Albumin fusion proteins |
| 08/09/2005 | US6926896 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction |
| 08/04/2005 | WO2005071071A1 Ptd-human choline acetyltransferase fusion protein and its application |
| 08/04/2005 | WO2005070959A2 Compositions comprising immune response altering agents and methods of use |
| 08/04/2005 | WO2004093807A3 Somatostatin vectors |
| 08/04/2005 | US20050170504 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/04/2005 | US20050170348 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 08/04/2005 | US20050169965 Compounds with improved cartilage-inducing and/or bone-inducing activity |
| 08/04/2005 | US20050169922 drug screening for compounds that enhance or suppress killer T cell activity by contacting killer T cells which express biliary glycoprotein with a compound that binds biliary glycoprotein and determining the cytotoxicity or proliferation of the killer T cells relative to a control |
| 08/04/2005 | CA2553756A1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications |
| 08/04/2005 | CA2553257A1 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
| 08/03/2005 | EP1558766A2 Use of a33 antigens and jam-it |
| 08/03/2005 | EP1558729A2 Rapidly degraded reporter fusion proteins |
| 08/03/2005 | EP1368050A4 Virus derived antimicrobial peptides |
| 08/03/2005 | EP1237900A4 Subunit optimized fusion proteins |
| 08/03/2005 | EP1049777B1 Acpl dna and polypeptides |
| 08/03/2005 | EP0914435B1 Hybrid interferon compositions and methods of use |
| 08/03/2005 | EP0755259B1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON |
| 08/03/2005 | CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/03/2005 | CN1648135A Transduction peptide-humanized chloine acetylase fusion protein and its use |
| 08/03/2005 | CN1213146C Process for producing recombinant insulin from novel fused protein |
| 08/02/2005 | US6924363 use in the separation and recovery of recombinant polypeptides from the cell due to the difference in densities between oil bodies and aqueous solutions |
| 08/02/2005 | US6924357 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy |
| 08/02/2005 | US6924268 Method for inactivating gonadotrophs |
| 08/02/2005 | US6924266 NTP-peptides and method for removal of tumors |
| 08/02/2005 | US6924135 DNA encoding Eimeria glyceroaldehyde-3-phosphate dehydrogenase and uses thereof |
| 08/02/2005 | US6924120 sequence linked to a target protein, preferably an insulin precursor; present invention also relates to a process for obtaining a correctly folded insulin-precursor |
| 08/02/2005 | US6924119 cGMP-visualizing probe and a method of detecting and quantifying of cGMP by using the same |
| 08/02/2005 | CA2078539C Process for producing humanized chimera antibody |
| 07/28/2005 | WO2005068616A2 Immunokinases |
| 07/28/2005 | WO2005068505A1 Fusion protein comprising tatdmt polypeptide |
| 07/28/2005 | WO2003072035A8 Compositions and methods for the treatment of immune related diseases |
| 07/28/2005 | US20050164933 Method of reducing injury to mammalian cells |
| 07/28/2005 | US20050164926 Novel recombinant anticoagulant proteins |
| 07/28/2005 | US20050164352 Immunoglobulin interleukin fusion for activating lymphoid precursor cells; treatment and prevention of infection |
| 07/28/2005 | US20050164247 isolated nucleic acid molecule wherein CD4+T cells over-expressing said nucleic acid sequence exhibits a reduction in CD3 and CD28 mediated T-cell proliferation; vector and host cell transformed with said nucleic acid |
| 07/28/2005 | US20050164185 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta |
| 07/28/2005 | US20050163799 Ditetics; useful for decreasing the amount of insulin necessary for the treatment of diabetes; Fc immunoglobulin region, derivative or analog fused to the N-terminal portion of the OB protein, derivative or analog |
| 07/28/2005 | US20050163794 Immunological herpes simplex virus antigens and methods for use thereof |
| 07/28/2005 | US20050163793 Methods for recovering peptides from stress protein-peptide complexes |
| 07/28/2005 | US20050163792 Stress protein joined to another component, such as a fusion protein in which a stress protein is fused to an antigen |
| 07/28/2005 | US20050163780 Administering antagonist of a GP39, selected from an antibody which specifically bind GP39, soluble CD40 and soluble CD40 fusion proteins |
| 07/28/2005 | US20050163744 Novel method for down-regulation of amyloid |
| 07/28/2005 | CA2553261A1 Immunokinases |
| 07/27/2005 | EP1557432A2 Hybrid proteins which form heterodimers |
| 07/27/2005 | EP1557173A1 Soluble CTLA4 mutant molecules and uses thereof |
| 07/27/2005 | EP0920510B1 GnRH-LEUKOTOXIN CHIMERAS |
| 07/27/2005 | CN1646567A Anti-idiotype anti-CEA antibody molecules and its use as cancer vaccine |
| 07/27/2005 | CN1646563A Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/27/2005 | CN1646154A Albumin-fused anti-angiogenesis peptides |
| 07/27/2005 | CN1212337C Tumour nascent blood ressel specificity conjugated polypeptide and human alpha interferon fusion protein and preparation |
| 07/26/2005 | US6921809 Immunoglobulin conjugate comprising amino acid sequences from dihydrolipoamide dehydrogenase (P64K) for use as tool in immunodetection of heterologous protein expression; vaccine development |
| 07/26/2005 | US6921534 Hepatitis B virus treatment |
| 07/26/2005 | US6921533 Method of using monoclonal antibodies against leukocyte adhesion receptor β-chain |
| 07/21/2005 | WO2005066203A2 Targeted immunogens |
| 07/21/2005 | WO2005065015A2 Neutralizing antibodies and methods of use thereof |
| 07/21/2005 | WO2004024064A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | WO2003057160A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | US20050158832 Secreted glycoprotein hormone fusion for use in regulating the level of red blood cells in circulation |
| 07/21/2005 | US20050158714 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 07/21/2005 | US20050158315 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 07/21/2005 | CA2552251A1 Targeted immunogens |
| 07/21/2005 | CA2548990A1 Toll-like receptor 4 (tlr4)-neutralizing antibodies |
| 07/20/2005 | EP1555328A2 Recombinant library screening methods |
| 07/20/2005 | EP1555316A2 Antigen library immunization |
| 07/20/2005 | EP1554572A2 Compositions and methods for modulating blood-brain barrier transport |
| 07/20/2005 | EP1554313A1 Regulation of the cre recombinase using a dissociation/re-association system of said recombinase |
| 07/20/2005 | EP1554307A2 Antagonists il-15 |
| 07/20/2005 | EP1553976A2 Hiv envelope-cd4 complexes and hybrids |